MedTrace Logo

Low-dose Droperidol for Prevention of Postoperative Delirium in Elderly Patients After Non-cardiac Surgery

NCT05401058 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2968

Last updated 2023-01-23

No results posted yet for this study

Summary

The aim of this multicenter, prospective, randomized, double-blind and large sample study is to explore the preventive effect of low-dose droperidol on POD in elderly patients after non-cardiac surgery, providing new approach for reducing the incidence of POD and improving the prognosis and quality of life.

Conditions

  • Digestive System Disease
  • Urologic Diseases
  • Gynecological Disease
  • Orthopedic Surgery

Interventions

DRUG

Droperidol Injection

About 30min before the end of operation, Droperidol 1.25mg/0.5ml will be administered by intravenous injection.

DRUG

Saline

About 30min before the end of operation, Normal saline 0.5ml will be administered by intravenous injection.

Sponsors & Collaborators

  • RenJi Hospital

    lead OTHER

Principal Investigators

  • Diansan Su, MD,PHD · Renji Hospital, Shanghai Jiaotong University, School of Medcine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-21
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05401058 on ClinicalTrials.gov